Terminated OBSERVATIONAL NCT00535158

Vitamin D 2 to Dialysis Patients (D2D)

Vitamin D and Muscle Strength in the Dialysis Population

Sponsor: Brigham and Women's Hospital

Conditions Fractures, Bone Kidney Disease Muscle Weakness Pain

Interventions Ergocalciferol (Vitamin D 2)

Updated 7 times since 2017 Last updated: Mar 14, 2017 Started: Jun 1, 2008 Primary completion: Jun 1, 2009 Completion: Jun 1, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Because of departure of study personnel and lack of funding

Other terminated trials from Brigham and Women's Hospital

See all terminations from Brigham and Women's Hospital

This observational or N/A phase trial investigates Fractures, Bone and Kidney Disease and is currently terminated or withdrawn. Brigham and Women's Hospital leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated
Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: NA → None

▶ Show 2 earlier versions

Apr 2017 — Apr 2018 [monthly]

Terminated NA

Status: Unknown Status → Terminated · Phase: PHASE4 → NA
Jan 2017 — Apr 2017 [monthly]

Unknown Status PHASE4

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brigham and Women's Hospital

Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.